How many 8-K filings has Xenon Pharmaceuticals Inc. filed?

Xenon Pharmaceuticals Inc. (XENE) has 10 8-K (Current Event Report) filings on record, spanning Mar 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Xenon Pharmaceuticals Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Xenon Pharmaceuticals Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Xenon Pharmaceuticals Inc. (XENE) — 8-K Filings

All 8-K filings from Xenon Pharmaceuticals Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

Xenon Pharmaceuticals Files 8-K on Officer/Director Changes — Dec 1, 2025 Risk: low
Xenon Pharmaceuticals Inc. filed an 8-K on November 24, 2025, reporting on the departure of directors or certain officers, the election of directors, the appoin
Xenon Pharmaceuticals Announces Board and Officer Changes — Oct 16, 2025 Risk: low
Xenon Pharmaceuticals Inc. announced on October 15, 2025, changes in its board and officer composition. The filing details the departure of certain directors an
Xenon Pharmaceuticals Announces Executive and Board Changes — Jul 3, 2025 Risk: low
On June 30, 2025, Xenon Pharmaceuticals Inc. reported changes in its executive and director roles. The company announced the appointment of Dr. Ian Mitchell as
Xenon Pharmaceuticals Files 8-K on Shareholder Votes & Exhibits — Jun 5, 2025 Risk: low
On June 4, 2025, Xenon Pharmaceuticals Inc. filed an 8-K report to disclose matters submitted to a vote of security holders and to file financial statements and
Xenon Pharmaceuticals Files 8-K — Mar 17, 2025 Risk: low
Xenon Pharmaceuticals Inc. filed an 8-K on March 17, 2025, reporting an event that occurred on March 14, 2025. The filing pertains to "Other Events" and "Financ
Xenon Pharmaceuticals Changes Auditor to Ernst & Young LLP — Mar 5, 2025 Risk: low
On March 3, 2025, Xenon Pharmaceuticals Inc. filed an 8-K report to disclose a change in its certifying accountant. The company has appointed Ernst & Young LLP
Xenon Pharmaceuticals Reports Director and Officer Changes — Jan 17, 2025 Risk: low
Xenon Pharmaceuticals Inc. filed an 8-K on January 17, 2025, reporting changes related to its board of directors and officers, including the election of directo
Xenon Pharmaceuticals Files 8-K for Shareholder Votes & Exhibits — Jun 5, 2024 Risk: low
Xenon Pharmaceuticals Inc. filed an 8-K on June 4, 2024, to report on matters submitted to a vote of security holders and to file financial statements and exhib
Xenon Pharmaceuticals Reports Director Changes and Compensation Updates — Apr 19, 2024 Risk: low
Xenon Pharmaceuticals Inc. announced on April 15, 2024, changes related to its board of directors and executive compensation. Specifically, the company reported
Xenon Pharmaceuticals Files 8-K Report — Mar 8, 2024 Risk: low
On March 8, 2024, Xenon Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicati

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX